Your browser doesn't support javascript.
loading
Comparison of Different Anti-Demodex Strategies: A Systematic Review and Meta-Analysis.
Li, Jiahua; Wei, Erdong; Reisinger, Amin; French, Lars Einar; Clanner-Engelshofen, Benjamin M; Reinholz, Markus.
Afiliación
  • Li J; Department of Dermatology and Allergy, University Hospital of Munich (LMU), Munich, Germany, jiahuali899@gmail.com.
  • Wei E; Department of Dermatology and Allergy, University Hospital of Munich (LMU), Munich, Germany.
  • Reisinger A; Department of Dermatology and Allergy, University Hospital of Munich (LMU), Munich, Germany.
  • French LE; Department of Dermatology and Allergy, University Hospital of Munich (LMU), Munich, Germany.
  • Clanner-Engelshofen BM; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA.
  • Reinholz M; Department of Dermatology and Allergy, University Hospital of Munich (LMU), Munich, Germany.
Dermatology ; 239(1): 12-31, 2023.
Article en En | MEDLINE | ID: mdl-36310014
ABSTRACT

BACKGROUND:

Demodex mites are related to some inflammatory diseases such as rosacea and blepharitis and could be harmful in patients with immunodeficiency or immunosuppression, especially notable in patients using biologic like dupilumab. In order to have an objective observation of different anti-Demodex strategies, we conducted this study, based on interventional clinical evidence with quantified Demodex mite data.

METHODS:

We used the PubMed, Embase, ClinicalTrials.gov, Medline, and International Clinical Trials Registry Platform (ICTRP) as databases. To assess the risk of bias, the RoB2 and ROBINS-I tools were used. The certainty of evidence was assessed following the GRADE guideline. Furthermore, the effect sizes (ESs) of different strategies were compared in different time periods (0-1, 1-2, 2-3, >3 months), as well as Demodex decrease rates.

RESULTS:

1,618 studies were identified in the databases, with 21 of which included in the final quantitative synthesis. Interventions in these studies included ivermectin, tea tree oil (TTO), permethrin, crotamiton, metronidazole, light therapies, combined therapies, and other therapies. During 0-1 month, the ES varied from 0.07 (cleanser) to 1.95 (systemic ivermectin-metronidazole). During 1-2 months, the ES varied from 0.88 (topical permethrin) to 4.40 (topical ivermectin). During 2-3 months, the ES varied from 0.79 (topical permethrin) to 8.37 (topical ivermectin). During the time of 3 months, the ES varied from 0.59 (topical permethrin) to 2.25 (intense pulsed light [IPL]). In terms of Demodex decrease rates, topical ivermectin, TTO, permethrin, IPL, and baby shampoo had achieved a nearly 100% decrease. The reported adverse events were mostly mild, without severe adverse events reported in any of the studies.

CONCLUSIONS:

We found ivermectin (topical and systemic), ivermectin-metronidazole (topical), and TTO (topical) are promising anti-Demodex interventions. In addition to traditional pharmacotherapy, light therapies, especially IPL and skin cleansing, could also be considered as effective methods to control Demodex mite infestation.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infestaciones por Ácaros / Ácaros Tipo de estudio: Guideline / Systematic_reviews Límite: Animals / Humans Idioma: En Revista: Dermatology Asunto de la revista: DERMATOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infestaciones por Ácaros / Ácaros Tipo de estudio: Guideline / Systematic_reviews Límite: Animals / Humans Idioma: En Revista: Dermatology Asunto de la revista: DERMATOLOGIA Año: 2023 Tipo del documento: Article